National Medical Products Administration approves the listing of Rosaceptide Injection.

Recently, the National Medical Products Administration approved the listing of Rosai Erythropoietin Alpha Injection by Guangdong Sansheng Pharmaceutical Co., Ltd. This product is used to treat anemia caused by chronic kidney disease in blood dialysis patients undergoing erythropoiesis-stimulating agent therapy. The listing of this product provides a new treatment option for relevant patients.